These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 11343868)

  • 21. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia.
    Eastwood SL; Burnet PW; Harrison PJ
    Neuroscience; 1995 May; 66(2):309-19. PubMed ID: 7477874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophrenia.
    Chambers JS; Thomas D; Saland L; Neve RL; Perrone-Bizzozero NI
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):283-90. PubMed ID: 15694236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased synaptophysin in the medial temporal lobe in schizophrenia demonstrated using immunoautoradiography.
    Eastwood SL; Harrison PJ
    Neuroscience; 1995 Nov; 69(2):339-43. PubMed ID: 8552231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
    Eastwood SL; Harrison PJ
    Schizophr Res; 2005 Mar; 73(2-3):159-72. PubMed ID: 15653259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice.
    Eastwood SL; Lyon L; George L; Andrieux A; Job D; Harrison PJ
    J Psychopharmacol; 2007 Aug; 21(6):635-44. PubMed ID: 17050659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia.
    Webster MJ; Shannon Weickert C; Herman MM; Hyde TM; Kleinman JE
    Schizophr Res; 2001 Apr; 49(1-2):89-98. PubMed ID: 11343868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia.
    Gothelf D; Soreni N; Nachman RP; Tyano S; Hiss Y; Reiner O; Weizman A
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):389-95. PubMed ID: 10974611
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 29.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 30.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.